Triptorelin

Known as: triptorelina, pGlu-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH2, TRIP 
A synthetic decapeptide agonist analog of luteinizing hormone releasing hormone (LHRH). Possessing greater potency than endogenous LHRH, triptorelin… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
IMPORTANCE Whether the administration of luteinizing hormone-releasing hormone analogues (LHRHa) during chemotherapy is a… (More)
  • figure 1
  • table 1
  • table 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2014
Highly Cited
2014
BACKGROUND Adjuvant therapy with an aromatase inhibitor improves outcomes, as compared with tamoxifen, in postmenopausal women… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2012
Highly Cited
2012
PURPOSE Chemotherapy-induced amenorrhea is a serious concern for women undergoing cancer therapy. This prospective randomized… (More)
Is this relevant?
Highly Cited
2011
Highly Cited
2011
CONTEXT Premenopausal patients with breast cancer are at high risk of premature ovarian failure induced by systemic treatments… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Replacing GnRH agonist cotreatment for the prevention of a premature rise in LH during ovarian stimulation for in vitro… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2002
Highly Cited
2002
Recently it was shown that a second GnRH system exists in primates. This study was conducted to investigate whether or not the… (More)
Is this relevant?
2001
2001
  • Human reproduction
  • 2001
This multicentre, randomized study was performed to assess the efficacy and safety of 0.25 mg ganirelix (Orgalutran, Antagon… (More)
Is this relevant?
Highly Cited
2000
Highly Cited
2000
A new treatment option for patients undergoing ovarian stimulation is the gonadotrophin-releasing hormone (GnRH) antagonist… (More)
  • table I
  • table II
Is this relevant?
1999
1999
The impact of treatment of central precocious puberty (CPP) with GnRH agonists on final statural height (FH) remains… (More)
Is this relevant?
1998
1998
OBJECTIVE To compare the effect of a GnRH-agonist, triptorelin, versus placebo on the symptoms of endometriosis. DESIGN A… (More)
Is this relevant?